We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA Mutations Identified in Chemotherapy-Resistant Cancer Cells

By Labmedica staff writers
Posted on 17 Apr 2008
The development of chemotherapy resistance was investigated in an in-vitro model of ovarian cancer.

Array comparative genomic hybridization (aCGH), gene expression profiling, and molecular cytogenetic analyses were used for genome profiling in cisplatin-resistant ovarian cancer cells. More...
aCGH detects genomic aberrations not evident by traditional cytogenetic techniques, whereas cytogenetic analysis detects structural changes not apparent by aCGH. Genomic interrogation that applies aCGH, gene expression profiling, and molecular cytogenetic analyses in a parallel fashion yields a much more comprehensive genomic profile to assess the chromosomal abnormalities associated with disease.

Using Agilent (Santa Clara, CA, USA) microarrays, scientists from the division of applied molecular oncology, Ontario Cancer Institute, Princess Margaret Hospital (OCI; Toronto, Canada) analyzed copy number and gene expression concurrently in an in-vitro model of ovarian cancer. The third component of the study included advanced molecular cytogenetic analyses. The results of this multi-front approach to genomic profiling enabled the group to identify relationships between particular genomic aberrations and expressed loci, and to reveal the origin of acquired chromosomal mutations in a drug-resistant cell line.

The study is available online in April 2008, in an early edition of the journal Genes Chromosomes Cancer.


Related Links:
Agilent
Ontario Cancer Institute, Princess Margaret Hospital

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.